就如东方树叶之于农夫山泉、无糖气泡水之于元气森林，每个赛道中的品牌佼佼者都有一个共同的特点——他们用极具辨识度的“超级产品”向消费者递出迅速占领心智的名片，以一“品”之力帮助企业在零售终端市...
EZVIZ has maintained its strong presence in this year’s competition, demonstrating its commitment to product excellence through effective design and great user experience
JAKARTA, Indonesia, Feb. 24...
Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ET
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups a...
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- ThreatLocker®, a global leader in Zero Trust cybersecurity, has unveiled new solutions that further advance its platform’s security and efficiency....
前 Takeda 副总裁 Tauhid Ali 博士担任董事会董事，他拥有卓越的领导能力和药物开发经验
监管战略家 Darren Rubin 担任 Amalive 副总裁，他拥有丰富的经验，负责开发氨清除剂 OPA，这是 Yaqrit 治疗肝性脑病的 ...
塞舌尔维多利亚, Feb. 21, 2025 (GLOBE NEWSWIRE) -- 领先的加密货币交易所和 Web3 公司 Bitget 与 CryptoRank 合作，对全球五大中心化加密货币交易所 (CEX) 的流动性深度进行了深入的比较分析，包括：Bin...
February 21, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2024.
Philips’ Annual Report 2024 w...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determinatio...
当全球生物医药产业迎来第三次技术革命浪潮，一场汇聚全球顶尖智慧的生物技术行业盛会即将启幕。由蛋白药研究会、广东省生物产业协会、广州医药行业协会、振威国际会展集团联合主办的BTE第9届国际生物技术大会暨展...
在全球公共卫生领域，糖尿病如同一道沉重的阴影，悄然威胁着无数人的健康。据国际糖尿病联盟的最新数据，我国成人糖尿病患病率已攀升至11.6%，更令人担忧的是，患者群体正逐渐年轻化。面对这一严峻挑战，糖尿病管理模...
